We are monitoring the impact of COVID-19 on North America Platelet Aggregation Devices Market Get in touch with us for detailed analysis Know More
Share on

North America Platelet Aggregation Devices Market Research Report - Segmented By Type, Application, End User & Country (US, Canada & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends & Forecasts (2022 to 2027)

Published: January, 2022
ID: 3404
Pages: 145

North America Platelet Aggregation Devices Market Size & Growth (2022 to 2027):

According to the report, the Size of the North America Platelet Aggregation Devices Market is valued at USD 107.10 million in 2022 and is estimated to be growing at a CAGR of 19.92%, to reach USD 265.61 million by 2027 during the forecast period 2022 to 2027.

The increase in the elderly growing population as more than 16.9 percent of in the US is elderly and 18 percent in Canada respectively, rising burden of chronic illnesses such as cancer, diabetes, hemophilia, etc., and technical developments in platelet aggregometer are all contributing to the growth of the platelet aggregation devices market.

Heart issues, such as stroke and coronary heart disease, are becoming more common, resulting in a global burden of cardiac mortality, which has fueled the expansion of the platelet aggregation devices market.

The continuous increase in the new advancements and developments in the technology is growing the demand in the market with the rise in the market players in platelet aggregometer.

Because of a large patient population for target diseases such as arthritis, leukemia, and hemophilia, a strong presence of device manufacturers in the region, with the growing number of surgical procedures performed annually, is increasing the market growth.

The platelet aggregation devices are used to treat a variety of cardiovascular and bleeding conditions, as well as an increase in the growing awareness among healthcare professionals related to the benefits and uses of platelet aggregation devices; therefore North American platelet aggregation devices market is expected to grow at a remarkable pace.

Rising awareness among healthcare professionals about the benefits offered by platelet aggregation testing in disease diagnosis as well as the factors such as an increase in the number of surgical procedures performed in the United States, a large percentage of the population undergoing cardiovascular surgery, and an increase in the prevalence of orthopedic, bleeding, and urological disorders are all creating high growth opportunities for the industry players.

Increases in average device costs throughout the world are limiting market growth, as is a shortage of qualified persons and flaws in old aggregometry methods, affecting market growth and advancements of platelet aggregation devices.

This research report on the North America Platelet Aggregation Devices Market has been segmented and sub-segmented into the following categories

By Product:

  • Systems
  • Reagents
  • Consumables
  • Accessories.

By Application:

  • Clinical applications
  • Cardiovascular applications
  • Orthopedic applications
  • Research applications

By End User:

  • Standalone hospitals
  • Diagnostic laboratories
  • Research
  • academic institutes

By Country:

  • US
  • Canada
  • Rest of North America

Geographically, the North American market covers the largest share in the platelet aggregation devices market, and it is expected to grow more significantly during the forecast period. Regionally, the market's growth is attributed to the presence of device manufacturers, an increasing number of target disorders, and an increasing geriatric population. In addition, growing research and development costs in this region may elevate the market expansion.

The US platelet aggregation devices market is expected to show more significant growth in the platelet aggregation devices market. There is a high prevalence of chronic diseases like diabetes, cancer, etc., where diabetes is one of America's fastest-growing diseases, uplifting market growth. According to recent research, more than 100 million individuals in the United States have diabetes or pre-diabetes illness. Also, because hemophilia is a bleeding condition, and platelet aggregation testing has proven to be highly effective in sickness detection, there's been a rise in hemophilia disorder in the United States.

Similarly, Canada platelet aggregation devices market has an increasing prevalence of chronic diseases, more than 12.9 percent. It is due to the increase in the overweight, obesity with an aging population, and socioeconomic changes leading to a continuous rise in these frequent and expensive long-term health issues. Therefore, people are becoming increasingly sedentary as the middle class expands and as urbanization accelerates.

KEY MARKET PLAYERS

Key Market Players dominating the North America Platelet Aggregation Devices Market are Accriva Diagnostics, Helena Laboratories Corporation, BioData Corporation, Haemonetics Corporation, Siemens AG, Sysmex Corporation, Sentinel CH. S.p.A., Tem Group and Aggredyne, Inc.

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                          

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                               

                2.2 Research Phases                      

                                2.2.1 Secondary Research           

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling      

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                       

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemiology                              

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                    

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market                              

5. Market Segmentation                                              

                5.1 Product                        

                                5.1.1 Introduction           

                                5.1.2 Systems   

                                5.1.3 Reagents 

                                5.1.4 Consumables and Accessories        

                                5.1.5  Y-o-Y Growth Analysis, By Product              

                                5.1.6  Market Attractiveness Analysis, By Product            

                                5.1.7  Market Share Analysis, By  Product             

                5.2 Application                 

                                5.2.1 Introduction           

                                5.2.2 Clinical Applications             

                                                5.2.2.1 Cardiovascular Applications

                                                5.2.2.2 Orthopedic Applications

                                                5.2.2.3 Other Clinical Applications

                                5.2.3 Research Applications        

                                5.2.4 Y-o-Y Growth Analysis, By Application         

                                5.2.5 Market Attractiveness Analysis, By Application       

                                5.2.6 Market Share Analysis, By Application        

                5.3 End-User                      

                                5.3.1 Introduction           

                                5.3.2 Standalone Hospitals          

                                5.3.3 Diagnostic Laboratories     

                                5.3.4 Research and Academic Institutes

                                5.3.5 Other End Users   

                                5.3.6 Y-o-Y Growth Analysis, By End User             

                                5.3.7  Market Attractiveness Analysis, By End User          

                                5.3.8  Market Share Analysis, By End User            

6. Geographical Analysis                                              

                6.1 Introduction                               

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Product

                                                6.1.3.3 Application

                                                6.1.3.4 By End User

                                6.1.4  Market Attractiveness Analysis     

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Product

                                                6.1.4.3 By Application

                                                6.1.4.4 By End User

                                6.1.5  Market Share Analysis      

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Product

                                                6.1.5.3 By Application

                                                6.1.5.4 By End User

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental       

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services              

                                7.2.5 Competitive Rivalry within the Industry     

8.Market Leaders' Analysis                                         

                8.1 Helena Laboratories Corporation                      

                                8.1.1 Overview 

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Haemonetics Corporation                    

                8.3 Siemens AG                               

                8.4 Sysmex Corporation                               

                8.5 Accriva Diagnostics                  

                8.6 Sentinel CH. S.p.A.                  

                8.7 Bio/Data Corporation                             

                8.8 Tem Group                 

                8.9 Aggredyne, Inc.                        

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                       

                9.3 Agreements, Collaborations, and Joint Ventures                         

                9.4 New Product Launches                         

10.Market Outlook and Investment Opportunities                                          

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  1. North America Platelet Aggregation Devices Market By Product, From 2022 - 2027 ( USD Million )
  2. North America Systems Market By Region, From 2022 - 2027 ( USD Million )
  3. North America Reagents Market By Region, From 2022 - 2027 ( USD Million )
  4. North America Consumables and Accessories Market By Region, From 2022 - 2027 ( USD Million )
  5. North America Platelet Aggregation Devices Market By Application, From 2022 - 2027 ( USD Million )
  6. North America Clinical Applications Market By Region, From 2022 - 2027 ( USD Million )
  7. North America Research Applications Market By Region, From 2022 - 2027 ( USD Million )
  8. North America Platelet Aggregation Devices Market By End User, From 2022 - 2027 ( USD Million )
  9. North America Standalone Hospitals Market By Region, From 2022 - 2027 ( USD Million )
  10. North America Diagnostic Laboratories Market By Region, From 2022 - 2027 ( USD Million )
  11. North America Research and Academic Institutes Market By Region, From 2022 - 2027 ( USD Million )
  12. North America Other End Users Market By Region, From 2022 - 2027 ( USD Million )
  13. United States Platelet Aggregation Devices Market By Product, From 2022 - 2027 ( USD Million )
  14. United States Platelet Aggregation Devices Market By Application, From 2022 - 2027 ( USD Million )
  15. United States Platelet Aggregation Devices Market By End User, From 2022 - 2027 ( USD Million )
  16. Canada Platelet Aggregation Devices Market By Product, From 2022 - 2027 ( USD Million )
  17. Canada Platelet Aggregation Devices Market By Application, From 2022 - 2027 ( USD Million )
  18. Canada Platelet Aggregation Devices Market By End User, From 2022 - 2027 ( USD Million )
  19. North America Platelet Aggregation Devices Market By Clinical Applications, From 2022 - 2027 ( USD Million )
  20. North America Cardiovascular Applications Market By Region, From 2022 - 2027 ( USD Million )
  21. North America Orthopedic Applications Market By Region, From 2022 - 2027 ( USD Million )
  22. North America Other Clinical Applications Market By Region, From 2022 - 2027 ( USD Million )
  23. United States Platelet Aggregation Devices Market By Clinical Applications, From 2022 - 2027 ( USD Million )
  24. Canada Platelet Aggregation Devices Market By Clinical Applications, From 2022 - 2027 ( USD Million )

Please wait. . . . Your request is being processed

Related Reports

PURCHASE OPTIONS

excel
$

3335


pdf excel
$

3680


pdf excel powerbi
$

5520


excel
$

2000

What You Get :

  • PDF Report Format.
  • Can be accessible by 1 single user.
  • 6 Months of Free Analyst Support.
  • PDF and Excel Datasheet Formats.
  • Can be accessible upto 2 to 5 users.
  • 1 Year of Free Analyst Support.
  • PDF, Excel and Power BI Dashboard.
  • Can be accessible by unlimited users.
  • 1 Year of Free Analyst Support.
  • Excel Datasheet Format.
  • Customized access as per user request.
  • Upgradable to other licenses.
customer-support
ASK FOR CUSTOMIZATION

Talk to our analyst and get customised report done according to your research needs

tag
INQUIRE FOR DISCOUNT

Check if you can avail any discount. Submit your details and our team will get back to you.

cloud-download
DOWNLOAD FREE SAMPLE

Request to avail a free sample report that reflects this market and its growth.

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 3335

Didn’t find what you’re looking for?
TALK TO OUR TEAM

Find it too expensive?
NO WORRIES!

Click for Request Sample